Literature DB >> 21564451

Cargo-dependent degradation of ESCRT-I as a feedback mechanism to modulate endosomal sorting.

Lene Malerød1, Nina Marie Pedersen, Catherine Elisabeth Sem Wegner, Viola Hélène Lobert, Edward Leithe, Andreas Brech, Edgar Rivedal, Knut Liestøl, Harald Stenmark.   

Abstract

Ligand-mediated lysosomal degradation of growth factor receptors, mediated by the endosomal sorting complex required for transport (ESCRT) machinery, is a mechanism that attenuates the cellular response to growth factors. In this article, we present a novel regulatory mechanism that involves ligand-mediated degradation of a key component of the sorting machinery itself. We have investigated the endosomal localization of subunits of the four ESCRTs-Hrs (ESCRT-0), Tsg101 (ESCRT-I), EAP30/Vps22 (ESCRT-II) and charged multivesicular body protein 3/Vps24 (ESCRT-III). All the components were detected on the limiting membrane of multivesicular endosomes (MVEs). Surprisingly, however, Tsg101 and other ESCRT-I subunits were also detected within intraluminal vesicles (ILVs) of MVEs. Tsg101 was sequestered along with cargo during endosomal sorting into ILVs and further degraded in lysosomes. Importantly, ESCRT-mediated downregulation of two distinct cargoes, epidermal growth factor receptor (EGFR) and connexin43, mutually made cells refractory to degradation of the other cargo. Our observations indicate that the degradation of a key ESCRT component along with cargo represents a novel feedback control of endosomal sorting by preventing collateral degradation of cell surface receptors following stimulation of one specific pathway.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564451     DOI: 10.1111/j.1600-0854.2011.01220.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  7 in total

1.  The endosomal sorting complex required for transport pathway mediates chemokine receptor CXCR4-promoted lysosomal degradation of the mammalian target of rapamycin antagonist DEPTOR.

Authors:  Rita Verma; Adriano Marchese
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

2.  AP-1/σ1B-Dependent SV Protein Recycling Is Regulated in Early Endosomes and Is Coupled to AP-2 Endocytosis.

Authors:  Manuel Kratzke; Ermes Candiello; Bernhard Schmidt; Olaf Jahn; Peter Schu
Journal:  Mol Neurobiol       Date:  2014-08-17       Impact factor: 5.590

3.  Binding to any ESCRT can mediate ubiquitin-independent cargo sorting.

Authors:  Shrawan Kumar Mageswaran; Megan Gorringe Dixon; Matt Curtiss; James P Keener; Markus Babst
Journal:  Traffic       Date:  2013-11-14       Impact factor: 6.215

4.  Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells.

Authors:  Olga Dolnik; Larissa Kolesnikova; Sonja Welsch; Thomas Strecker; Gordian Schudt; Stephan Becker
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

5.  Concerted ESCRT and clathrin recruitment waves define the timing and morphology of intraluminal vesicle formation.

Authors:  Eva Maria Wenzel; Sebastian Wolfgang Schultz; Kay Oliver Schink; Nina Marie Pedersen; Viola Nähse; Andreas Carlson; Andreas Brech; Harald Stenmark; Camilla Raiborg
Journal:  Nat Commun       Date:  2018-07-26       Impact factor: 14.919

Review 6.  Regulation of gap junction intercellular communication by connexin ubiquitination: physiological and pathophysiological implications.

Authors:  Max Zachrisson Totland; Nikoline Lander Rasmussen; Lars Mørland Knudsen; Edward Leithe
Journal:  Cell Mol Life Sci       Date:  2019-09-09       Impact factor: 9.261

7.  Alteration of the late endocytic pathway in Charcot-Marie-Tooth type 2B disease.

Authors:  Roberta Romano; Cristina Rivellini; Maria De Luca; Rossana Tonlorenzi; Raffaella Beli; Fiore Manganelli; Maria Nolano; Lucio Santoro; Eeva-Liisa Eskelinen; Stefano C Previtali; Cecilia Bucci
Journal:  Cell Mol Life Sci       Date:  2020-04-13       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.